Search

Your search keyword '"Henry L. Paulson"' showing total 305 results

Search Constraints

Start Over You searched for: Author "Henry L. Paulson" Remove constraint Author: "Henry L. Paulson"
305 results on '"Henry L. Paulson"'

Search Results

1. Wild-type and pathogenic forms of ubiquilin 2 differentially modulate components of the autophagy-lysosome pathways

2. Associations of healthy lifestyle and socioeconomic status with cognitive function in U.S. older adults

3. Upregulation of the ESCRT pathway and multivesicular bodies accelerates degradation of proteins associated with neurodegeneration

4. Ubiquilin-2 regulates pathological alpha-synuclein

5. Quantitative flow cytometric selection of tau conformational nanobodies specific for pathological aggregates

6. Regional and age-dependent changes in ubiquitination in cellular and mouse models of spinocerebellar ataxia type 3

7. Derivation of spinocerebellar ataxia type 3 human embryonic stem cell line UMICHe001-A/UM134-1

8. Shared and divergent phase separation and aggregation properties of brain-expressed ubiquilins

9. Sleep Alterations in a Mouse Model of Spinocerebellar Ataxia Type 3

10. Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases

11. Fbxo2 mediates clearance of damaged lysosomes and modifies neurodegeneration in the Niemann-Pick C brain

12. Modeling UBQLN2-mediated neurodegenerative disease in mice: Shared and divergent properties of wild type and mutant UBQLN2 in phase separation, subcellular localization, altered proteostasis pathways, and selective cytotoxicity

13. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein

14. Pathogenesis of SCA3 and implications for other polyglutamine diseases

15. The ubiquitin conjugating enzyme Ube2W regulates solubility of the Huntington's disease protein, huntingtin

16. Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models

17. Differential toxicity of ataxin-3 isoforms in Drosophila models of Spinocerebellar Ataxia Type 3

18. Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line

19. Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3

20. Alterations in cerebellar physiology are associated with a stiff-legged gait in Atcayji-hes mice

21. Transcriptional changes and developmental abnormalities in a zebrafish model of myotonic dystrophy type 1

22. Splice isoform-specific suppression of the CaV2.1 variant underlying spinocerebellar ataxia type 6

23. In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis

24. Allosteric regulation of deubiquitylase activity through ubiquitination

25. Characterization of an Expanded Glutamine Repeat Androgen Receptor in a Neuronal Cell Culture System

27. Research Priorities of Individuals and Caregivers With Lewy Body Dementia

28. New insights into the genetic etiology of Alzheimer's disease and related dementias

29. Disrupting the Balance of Protein Quality Control Protein UBQLN2 Accelerates Tau Proteinopathy

30. Impaired Oligodendrocyte Maturation Is an Early Feature in SCA3 Disease Pathogenesis

31. Plasma phospho‐tau predicts differences in white matter microstructural complexity and cognition in non‐demented older adults

32. The S-Factor, a New Measure of Disease Severity in Spinocerebellar Ataxia: Findings and Implications

33. The association between obstructive sleep apnea risk and cognitive disorders: a population-based study

34. Ubiquilin-2 differentially regulates polyglutamine disease proteins

35. Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers

36. Caregiver-Reported Barriers to Quality End-of-Life Care in Dementia With Lewy Bodies: A Qualitative Analysis

37. Ubiquilin-2 regulates pathological alpha-synuclein

38. Validation of the National Alzheimer's Coordinating Center (NACC) Lewy Body Disease Module neuropsychological tests

39. GRASP55 regulates the unconventional secretion and aggregation of mutant huntingtin

40. GRASP55 regulates mutant huntingtin unconventional secretion and aggregation

41. Peri-Infarct Upregulation of the Oxytocin Receptor in Vascular Dementia

42. RTL8 promotes nuclear localization of UBQLN2 to subnuclear compartments associated with protein quality control

43. Shared and divergent phase separation and aggregation properties of brain-expressed ubiquilins

44. Ubiquilin‐2 exacerbates tau toxicity in vivo

45. Therapeutic potential of oxytocin receptor signaling in vascular dementia

46. Diagnostic differentiation by NIH Toolbox‐Cognition (iPAD) for Alzheimer’s disease, mild cognitive impairment (MCI), and healthy control participants

47. Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3

48. Fbxo2 mediates clearance of damaged lysosomes and modifies neurodegeneration in the Niemann-Pick C brain

49. Antisense Oligonucleotide Therapy Targeted Against ATXN3 Improves Potassium Channel-Mediated Purkinje Neuron Dysfunction in Spinocerebellar Ataxia Type 3

Catalog

Books, media, physical & digital resources